[1] Li J,Liu W,Zhu W,et al.Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials. Oncotarget,2017,8:59601-59608.
[2] 陈劲松,黄炯强,董世濠,等.微小RNA-379-5p对肝癌细胞迁移和侵袭的影响.中华医学杂志,2016,96:1450-1453.
[3] 范梦恬,陈思成,郭杨柳,等.趋化因子受体CX3CR1对人肝癌细胞7721和HepG2的作用及其机制的研究.中国生物工程杂志,2017, 37:22-30.
[4] Liu K,Fan J,Wu J.Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways.Drug Discov Ther,2017,11:212-217.
[5] Lin X,Chang W,Wang Y,et al.SRPX2,an independent prognostic marker,promotes cell migration and invasion in hepatocellular carcinoma.Biomed Pharmacother,2017,93:398-405.
[6] 李婷,彭波.SRPX2在胃癌中的表达及对细胞侵袭的影响.中国现代医学杂志,2017,27:36-40.
[7] Jablońska-Trypuc' A,Matejczyk M,Rosochacki S.Matrix metalloproteinases (MMPs),the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.J Enzyme Inhib Med Chem,2016,31:177-183.
[8] 王曼,朱振红,朱正秋.MACC1调节肝星状细胞表达MMP-2、MMP-9对胃癌细胞迁移侵袭能力的影响.胃肠病学和肝病学杂志,2016, 25:765-768. |